Transcriptional analysis of apoptotic cerebellar granule neurons following rescue by gastric inhibitory polypeptide

International Journal of Molecular Sciences

Volumn 15, Issue 4, 2014, Pages 5596-5622

  Maino, Barbara ^a   Ciotti, Maria Teresa ^b   Calissano, Pietro ^b   Cavallaro, Sebastiano ^a  

^a INSTITUTE OF NEUROLOGICAL SCIENCES   (Italy)

^b EUROPEAN BRAIN RESEARCH INSTITUTE   (Italy)

Author keywords

Apoptosis; Cerebellar granule neurons (CGNs); Gastric inhibitory polypeptide (Gip); Gene expression; Pathway; Rescue; Survival; Transcriptional program

Indexed keywords

GASTRIC INHIBITORY POLYPEPTIDE; ANTIOXIDANT;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL SURVIVAL; DNA MICROARRAY; GENE EXPRESSION; GENE SEQUENCE; GENOME ANALYSIS; GRANULE CELL; NEUROPROTECTION; NONHUMAN; NUCLEOTIDE SEQUENCE; RAT; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; ANIMAL; CELL CYCLE CHECKPOINT; CEREBELLUM; CYTOLOGY; GENE EXPRESSION PROFILING; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; NERVE CELL; UBIQUITINATION; WISTAR RAT;

ANIMALS; ANTIOXIDANTS; APOPTOSIS; CELL CYCLE CHECKPOINTS; CEREBELLUM; GASTRIC INHIBITORY POLYPEPTIDE; GENE EXPRESSION PROFILING; NEURONS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RATS; RATS, WISTAR; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC; UBIQUITINATION;

EID: 84897434495     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms15045596     Document Type: Article

References (194)

1. Jellinger, K.A. Challenges in neuronal apoptosis. Curr. Alzheimer Res. 2006, 3, 377-391.
2. Arends, M.J.; Wyllie, A.H. Apoptosis: Mechanisms and roles in pathology. Internatl. Rev. Exp. Pathol. 1991, 32, 223-254.
3. Oppenheim, R.W. Cell death during development of the nervous system. Annu. Rev. Neurosci. 1991, 14, 453-501.
4. Pettmann, B.; Henderson, C.E. Neuronal cell death. Neuron 1998, 20, 633-647.
5. Mattson, M.P. Neuronal life-and-death signaling, apoptosis, and neurodegenerative disorders. Antioxid. Redox Signal. 2006, 8, 1997-2006.
6. D'Mello, S.R.; Chin, P.C. Treating neurodegenerative conditions through the understanding of neuronal apoptosis. Curr. Drug Targets 2005, 4, 3-23.
7. Contestabile, A. Cerebellar granule cells as a model to study mechanisms of neuronal apoptosis or survival in vivo and in vitro. Cerebellum 2002, 1, 41-55.
8. D'Mello, S.R.; Galli, C.; Ciotti, T.; Calissano, P. Induction of apoptosis in cerebellar granule neurons by low potassium: Inhibition of death by insulin-like growth factor i and camp. Proc. Natl. Acad. Sci. USA 1993, 90, 10989-10993.
9. Gallo, V.; Ciotti, M.T.; Coletti, A.; Aloisi, F.; Levi, G. Selective release of glutamate from cerebellar granule cells differentiating in culture. Proc. Natl. Acad. Sci. USA 1982, 79, 7919-7923.
10. +-atpase activity in cultured rat cerebellar granule cells prevents the onset of apoptosis induced by low potassium. Neurosci. Lett. 2000, 283, 41-44.
11. Wood, K.A.; Dipasquale, B.; Youle, R.J. In situ labeling of granule cells for apoptosis-associated DNA fragmentation reveals different mechanisms of cell loss in developing cerebellum. Neuron 1993, 11, 621-632.
12. Tanaka, M.; Marunouchi, T. Immunohistochemical analysis of developmental stage of external granular layer neurons which undergo apoptosis in postnatal rat cerebellum. Neurosci. Lett. 1998, 242, 85-88.
13. Nikolic, M.; Gardner, H.A.; Tucker, K.L. Postnatal neuronal apoptosis in the cerebral cortex: Physiological and pathophysiological mechanisms. Neuroscience 2013, 254, 369-378.
14. Galli, C.; Meucci, O.; Scorziello, A.; Werge, T.M.; Calissano, P.; Schettini, G. Apoptosis in cerebellar granule cells is blocked by high kcl, forskolin, and igf-1 through distinct mechanisms of action: The involvement of intracellular calcium and rna synthesis. J. Neurosci. 1995, 15, 1172-1179.
15. Cavallaro, S.; Copani, A.; D'Agata, V.; Musco, S.; Petralia, S.; Ventra, C.; Stivala, F.; Travali, S.; Canonico, P.L. Pituitary adenylate cyclase activating polypeptide prevents apoptosis in cultured cerebellar granule neurons. Mol. Pharmacol. 1996, 50, 60-66.
16. Paratore, S.; Ciotti, M.T.; Basille, M.; Vaudry, D.; Gentile, A.; Parenti, R.; Calissano, P.; Cavallaro, S. Gastric inhibitory polypeptide and its receptor are expressed in the central nervous system and support neuronal survival. Cent. Nerv. Syst. Agent Med. Chem. 2011, 11, 210-222.
17. Inagaki, N.; Seino, Y.; Takeda, J.; Yano, H.; Yamada, Y.; Bell, G.I.; Eddy, R.L.; Fukushima, Y.; Byers, M.G.; Shows, T.B.; et al. Gastric inhibitory polypeptide: Structure and chromosomal localization of the human gene. Mol. Endocrinol. 1989, 3, 1014-1021.
18. Tseng, C.C.; Jarboe, L.A.; Landau, S.B.; Williams, E.K.; Wolfe, M.M. Glucose-dependent insulinotropic peptide: Structure of the precursor and tissue-specific expression in rat. Proc. Natl. Acad. Sci. USA 1993, 90, 1992-1996.
19. Ojima, A.; Matsui, T.; Maeda, S.; Takeuchi, M.; Yamagishi, S. Glucose-dependent insulinotropic polypeptide (gip) inhibits signaling pathways of advanced glycation end products (ages) in endothelial cells via its antioxidative properties. Horm. Metab. Res. 2012, 44, 501-505.
20. Harada, N. Structure and function of incretin receptor. Nihon Rinsho 2011, 69, 813-820. (in Japanese)
21. Yamada, Y.; Hayami, T.; Nakamura, K.; Kaisaki, P.J.; Someya, Y.; Wang, C.Z.; Seino, S.; Seino, Y. Human gastric inhibitory polypeptide receptor: Cloning of the gene (gipr) and cdna. Genomics 1995, 29, 773-776.
22. Gremlich, S.; Porret, A.; Hani, E.H.; Cherif, D.; Vionnet, N.; Froguel, P.; Thorens, B. Cloning, functional expression, and chromosomal localization of the human pancreatic islet glucose-dependent insulinotropic polypeptide receptor. Diabetes 1995, 44, 1202-1208.
23. Hauner, H.; Glatting, G.; Kaminska, D.; Pfeiffer, E.F. Effects of gastric inhibitory polypeptide on glucose and lipid metabolism of isolated rat adipocytes. Ann. Nutr. Metab. 1988, 32, 282-288.
24. Kogire, M.; Inoue, K.; Sumi, S.; Doi, R.; Yun, M.; Kaji, H.; Tobe, T. Effects of gastric inhibitory polypeptide and glucagon on portal venous and hepatic arterial flow in conscious dogs. Digest. Dis. Sci. 1992, 37, 1666-1670.
25. Holst, J.J. On the physiology of gip and glp-1. Horm. Metab. Res. 2004, 36, 747-754.
26. Hansotia, T.; Drucker, D.J. Gip and glp-1 as incretin hormones: Lessons from single and double incretin receptor knockout mice. Regul. Pept. 2005, 128, 125-134.
27. Gault, V.A.; Harriott, P.; Flatt, P.R.; O'Harte, F.P. Cyclic amp production and insulin releasing activity of synthetic fragment peptides of glucose-dependent insulinotropic polypeptide. Biosci. Rep. 2002, 22, 523-528.
28. Ehses, J.A.; Lee, S.S.; Pederson, R.A.; McIntosh, C.H. A new pathway for glucose-dependent insulinotropic polypeptide (gip) receptor signaling: Evidence for the involvement of phospholipase a2 in gip-stimulated insulin secretion. J. Biol. Chem. 2001, 276, 23667-23673.
29. Volz, A.; Goke, R.; Lankat-Buttgereit, B.; Fehmann, H.C.; Bode, H.P.; Goke, B. Molecular cloning, functional expression, and signal transduction of the gip-receptor cloned from a human insulinoma. FEBS Lett. 1995, 373, 23-29.
30. Brubaker, P.L.; Drucker, D.J. Structure-function of the glucagon receptor family of g protein-coupled receptors: The glucagon, gip, glp-1, and glp-2 receptors. Recept. Channels 2002, 8, 179-188.
31. Kaplan, A.M.; Vigna, S.R. Gastric inhibitory polypeptide (gip) binding sites in rat brain. Peptides 1994, 15, 297-302.
32. Gault, V.A.; Holscher, C. Protease-resistant glucose-dependent insulinotropic polypeptide agonists facilitate hippocampal ltp and reverse the impairment of ltp induced by beta-amyloid. J. Neurophysiol. 2008, 99, 1590-1595.
33. Figueiredo, C.P.; Pamplona, F.A.; Mazzuco, T.L.; Aguiar, A.S., Jr.; Walz, R.; Prediger, R.D. Role of the glucose-dependent insulinotropic polypeptide and its receptor in the central nervous system: Therapeutic potential in neurological diseases. Behav. Pharmacol. 2010, 21, 394-408.
34. Faivre, E.; Gault, V.A.; Thorens, B.; Holscher, C. Glucose-dependent insulinotropic polypeptide receptor knockout mice are impaired in learning, synaptic plasticity, and neurogenesis. J. Neurophysiol. 2011, 105, 1574-1580.
35. Buhren, B.A.; Gasis, M.; Thorens, B.; Muller, H.W.; Bosse, F. Glucose-dependent insulinotropic polypeptide (gip) and its receptor (gipr): Cellular localization, lesion-affected expression, and impaired regenerative axonal growth. J. Neurosci. Res. 2009, 87, 1858-1870.
36. Nyberg, J.; Jacobsson, C.; Anderson, M.F.; Eriksson, P.S. Immunohistochemical distribution of glucose-dependent insulinotropic polypeptide in the adult rat brain. J. Neurosci. Res. 2007, 85, 2099-2119.
37. Nyberg, J.; Anderson, M.F.; Meister, B.; Alborn, A.M.; Strom, A.K.; Brederlau, A.; Illerskog, A.C.; Nilsson, O.; Kieffer, T.J.; Hietala, M.A.; et al. Glucose-dependent insulinotropic polypeptide is expressed in adult hippocampus and induces progenitor cell proliferation. J. Neurosci. 2005, 25, 1816-1825.
38. Kim, S.J.; Ao, Z.; Warnock, G.; McIntosh, C.H. Incretin-stimulated interaction between beta-cell kv1.5 and kvbeta2 channel proteins involves acetylation/deacetylation by cbp/sirt1. Biochem. J. 2013, 451, 227-234.
39. Yabe, D.; Seino, Y. Two incretin hormones glp-1 and gip: Comparison of their actions in insulin secretion and beta cell preservation. Prog. Biophys. Mol. Biol. 2011, 107, 248-256.
40. Campbell, R.K. Fate of the beta-cell in the pathophysiology of type 2 diabetes. J. Am. Pharm. Assoc. 2009, 49, S10-S15.
41. Maida, A.; Hansotia, T.; Longuet, C.; Seino, Y.; Drucker, D.J. Differential importance of glucose-dependent insulinotropic polypeptide vs. glucagon-like peptide 1 receptor signaling for beta cell survival in mice. Gastroenterology 2009, 137, 2146-2157.
42. Widenmaier, S.B.; Ao, Z.; Kim, S.J.; Warnock, G.; McIntosh, C.H. Suppression of p38 mapk and jnk via akt-mediated inhibition of apoptosis signal-regulating kinase 1 constitutes a core component of the beta-cell pro-survival effects of glucose-dependent insulinotropic polypeptide. J. Biol. Chem. 2009, 284, 30372-30382.
43. Kim, S.J.; Nian, C.; Widenmaier, S.; McIntosh, C.H. Glucose-dependent insulinotropic polypeptide-mediated up-regulation of beta-cell antiapoptotic bcl-2 gene expression is coordinated by cyclic amp (camp) response element binding protein (creb) and camp-responsive creb coactivator 2. Mol. Cell. Biol. 2008, 28, 1644-1656.
44. Trumper, A.; Trumper, K.; Horsch, D. Mechanisms of mitogenic and anti-apoptotic signaling by glucose-dependent insulinotropic polypeptide in beta(ins-1)-cells. J. Endocrinol. 2002, 174, 233-246.
45. Kim, S.J.; Winter, K.; Nian, C.; Tsuneoka, M.; Koda, Y.; McIntosh, C.H. Glucose-dependent insulinotropic polypeptide (gip) stimulation of pancreatic beta-cell survival is dependent upon phosphatidylinositol 3-kinase (pi3k)/protein kinase b (pkb) signaling, inactivation of the forkhead transcription factor foxo1, and down-regulation of bax expression. J. Biol. Chem. 2005, 280, 22297-22307.
46. Lyssenko, V.; Eliasson, L.; Kotova, O.; Pilgaard, K.; Wierup, N.; Salehi, A.; Wendt, A.; Jonsson, A.; de Marinis, Y.Z.; Berglund, L.M.; et al. Pleiotropic effects of gip on islet function involve osteopontin. Diabetes 2011, 60, 2424-2433.
47. Tsukiyama, K.; Yamada, Y.; Yamada, C.; Harada, N.; Kawasaki, Y.; Ogura, M.; Bessho, K.; Li, M.; Amizuka, N.; Sato, M.; et al. Gastric inhibitory polypeptide as an endogenous factor promoting new bone formation after food ingestion. Mol. Endocrinol. 2006, 20, 1644-1651.
48. Kubota, A.; Yamada, Y.; Yasuda, K.; Someya, Y.; Ihara, Y.; Kagimoto, S.; Watanabe, R.; Kuroe, A.; Ishida, H.; Seino, Y. Gastric inhibitory polypeptide activates map kinase through the wortmannin-sensitive and -insensitive pathways. Biochem. Biophys. Res. Commun. 1997, 235, 171-175.
49. Ehses, J.A.; Casilla, V.R.; Doty, T.; Pospisilik, J.A.; Winter, K.D.; Demuth, H.U.; Pederson, R.A.; McIntosh, C.H. Glucose-dependent insulinotropic polypeptide promotes beta-(ins-1) cell survival via cyclic adenosine monophosphate-mediated caspase-3 inhibition and regulation of p38 mitogen-activated protein kinase. Endocrinology 2003, 144, 4433-4445.
50. Yasuda, K.; Inagaki, N.; Yamada, Y.; Kubota, A.; Seino, S.; Seino, Y. Hamster gastric inhibitory polypeptide receptor expressed in pancreatic islets and clonal insulin-secreting cells: Its structure and functional properties. Biochem. Biophys. Res. Commun. 1994, 205, 1556-1562.
51. Zeng, X.J.; Yu, S.P.; Zhang, L.; Wei, L. Neuroprotective effect of the endogenous neural peptide apelin in cultured mouse cortical neurons. Exp. Cell Res. 2010, 316, 1773-1783.
52. O'Donnell, L.A.; Agrawal, A.; Sabnekar, P.; Dichter, M.A.; Lynch, D.R.; Kolson, D.L. Apelin, an endogenous neuronal peptide, protects hippocampal neurons against excitotoxic injury. J. Neurochem. 2007, 102, 1905-1917.
53. Reaux, A.; de Mota, N.; Skultetyova, I.; Lenkei, Z.; El Messari, S.; Gallatz, K.; Corvol, P.; Palkovits, M.; Llorens-Cortes, C. Physiological role of a novel neuropeptide, apelin, and its receptor in the rat brain. J. Neurochem. 2001, 77, 1085-1096.
54. Cook, D.R.; Gleichman, A.J.; Cross, S.A.; Doshi, S.; Ho, W.; Jordan-Sciutto, K.L.; Lynch, D.R.; Kolson, D.L. Nmda receptor modulation by the neuropeptide apelin: Implications for excitotoxic injury. J. Neurochem. 2011, 118, 1113-1123.
55. Kasai, A.; Kinjo, T.; Ishihara, R.; Sakai, I.; Ishimaru, Y.; Yoshioka, Y.; Yamamuro, A.; Ishige, K.; Ito, Y.; Maeda, S. Apelin deficiency accelerates the progression of amyotrophic lateral sclerosis. PLoS One 2011, 6, e23968.
56. Morganti, J.M.; Nash, K.R.; Grimmig, B.A.; Ranjit, S.; Small, B.; Bickford, P.C.; Gemma, C. The soluble isoform of cx3cl1 is necessary for neuroprotection in a mouse model of parkinson's disease. J. Neurosci. 2012, 32, 14592-14601.
57. Hao, F.; Zhang, N.N.; Zhang, D.M.; Bai, H.Y.; Piao, H.; Yuan, B.; Zhu, H.Y.; Yu, H.; Xiao, C.S.; Li, A.P. Chemokine fractalkine attenuates overactivation and apoptosis of bv-2 microglial cells induced by extracellular atp. Neurochem. Res. 2013, 38, 1002-1012.
58. Cipriani, R.; Villa, P.; Chece, G.; Lauro, C.; Paladini, A.; Micotti, E.; Perego, C.; de Simoni, M.G.; Fredholm, B.B.; Eusebi, F.; et al. Cx3cl1 is neuroprotective in permanent focal cerebral ischemia in rodents. J. Neurosci. 2011, 31, 16327-16335.
59. Lauro, C.; Cipriani, R.; Catalano, M.; Trettel, F.; Chece, G.; Brusadin, V.; Antonilli, L.; van Rooijen, N.; Eusebi, F.; Fredholm, B.B.; et al. Adenosine a1 receptors and microglial cells mediate cx3cl1-induced protection of hippocampal neurons against glu-induced death. Neuropsychopharmacology 2010, 35, 1550-1559.
60. Noda, M.; Doi, Y.; Liang, J.; Kawanokuchi, J.; Sonobe, Y.; Takeuchi, H.; Mizuno, T.; Suzumura, A. Fractalkine attenuates excito-neurotoxicity via microglial clearance of damaged neurons and antioxidant enzyme heme oxygenase-1 expression. J. Biol. Chem. 2011, 286, 2308-2319.
61. Boehme, S.A.; Lio, F.M.; Maciejewski-Lenoir, D.; Bacon, K.B.; Conlon, P.J. The chemokine fractalkine inhibits fas-mediated cell death of brain microglia. J. Immunol. 2000, 165, 397-403.
62. Cook, A.; Hippensteel, R.; Shimizu, S.; Nicolai, J.; Fatatis, A.; Meucci, O. Interactions between chemokines: Regulation of fractalkine/cx3cl1 homeostasis by sdf/cxcl12 in cortical neurons. J. Biol. Chem. 2010, 285, 10563-10571.
63. Catalano, M.; Lauro, C.; Cipriani, R.; Chece, G.; Ponzetta, A.; di Angelantonio, S.; Ragozzino, D.; Limatola, C. Cx3cl1 protects neurons against excitotoxicity enhancing glt-1 activity on astrocytes. J. Neuroimmunol. 2013, 263, 75-82.
64. Yuan, Q.; Chiquet, B.T.; Devault, L.; Warman, M.L.; Nakamura, Y.; Swindell, E.C.; Hecht, J.T. Craniofacial abnormalities result from knock down of nonsyndromic clefting gene, crispld2, in zebrafish. Genesis 2012, 50, 871-881.
65. Szlama, G.; Kondas, K.; Trexler, M.; Patthy, L. Wfikkn1 and wfikkn2 bind growth factors tgfbeta1, bmp2 and bmp4 but do not inhibit their signalling activity. FEBS J. 2010, 277, 5040-5050.
66. Liu, Y.; Cheng, H.; Zhou, Y.; Zhu, Y.; Bian, R.; Chen, Y.; Li, C.; Ma, Q.; Zheng, Q.; Zhang, Y.; et al. Myostatin induces mitochondrial metabolic alteration and typical apoptosis in cancer cells. Cell Death Dis. 2013, 4, e494.
67. Holzbaur, E.L.; Howland, D.S.; Weber, N.; Wallace, K.; She, Y.; Kwak, S.; Tchistiakova, L.A.; Murphy, E.; Hinson, J.; Karim, R.; et al. Myostatin inhibition slows muscle atrophy in rodent models of amyotrophic lateral sclerosis. Neurobiol. Dis. 2006, 23, 697-707.
68. Filipe, M.; Goncalves, L.; Bento, M.; Silva, A.C.; Belo, J.A. Comparative expression of mouse and chicken shisa homologues during early development. Dev. Dyn. 2006, 235, 2567-2573.
69. Pei, J.; Grishin, N.V. Unexpected diversity in shisa-like proteins suggests the importance of their roles as transmembrane adaptors. Cell Signal. 2012, 24, 758-769.
70. Schultze, W.; Eulenburg, V.; Lessmann, V.; Herrmann, L.; Dittmar, T.; Gundelfinger, E.D.; Heumann, R.; Erdmann, K.S. Semaphorin4f interacts with the synapse-associated protein sap90/psd-95. J. Neurochem. 2001, 78, 482-489.
71. Barrette, B.; Calvo, E.; Vallieres, N.; Lacroix, S. Transcriptional profiling of the injured sciatic nerve of mice carrying the Wld(s) mutant gene: Identification of genes involved in neuroprotection, neuroinflammation, and nerve regeneration. Brain Behav. Immun. 2010, 24, 1254-1267.
72. Li, T.S.; Li, X.N.; Chang, Z.J.; Fu, X.Y.; Liu, L. Identification and functional characterization of a novel interleukin 17 receptor: A possible mitogenic activation through ras/mitogen-activated protein kinase signaling pathway. Cell Signal. 2006, 18, 1287-1298.
73. Moseley, T.A.; Haudenschild, D.R.; Rose, L.; Reddi, A.H. Interleukin-17 family and il-17 receptors. Cytokine Growth Factor Rev. 2003, 14, 155-174.
74. Vidlak, D.; Kielian, T. Differential effects of interleukin-17 receptor signaling on innate and adaptive immunity during central nervous system bacterial infection. J. Neuroinflam. 2012, 9, 128.
75. Bonni, A.; Brunet, A.; West, A.E.; Datta, S.R.; Takasu, M.A.; Greenberg, M.E. Cell survival promoted by the ras-mapk signaling pathway by transcription-dependent and independent mechanisms. Science 1999, 286, 1358-1362.
76. 2+/calmodulin-dependent kinase pathway. J. Biol. Chem. 1996, 271, 28105-28111.
77. Ono, T.; Inokuchi, K.; Ogura, A.; Ikawa, Y.; Kudo, Y.; Kawashima, S. Activity-dependent expression of parathyroid hormone-related protein (pthrp) in rat cerebellar granule neurons. Requirement of pthrp for the activity-dependent survival of granule neurons. J. Biol. Chem. 1997, 272, 14404-14411.
78. Chatterjee, O.; Nakchbandi, I.A.; Philbrick, W.M.; Dreyer, B.E.; Zhang, J.P.; Kaczmarek, L.K.; Brines, M.L.; Broadus, A.E. Endogenous parathyroid hormone-related protein functions as a neuroprotective agent. Brain Res. 2002, 930, 58-66.
79. Brines, M.L.; Ling, Z.; Broadus, A.E. Parathyroid hormone-related protein protects against kainic acid excitotoxicity in rat cerebellar granule cells by regulating l-type channel calcium flux. Neurosci. Lett. 1999, 274, 13-16.
80. Gessi, M.; Monego, G.; Calviello, G.; Lanza, P.; Giangaspero, F.; Silvestrini, A.; Lauriola, L.; Ranelletti, F.O. Human parathyroid hormone-related protein and human parathyroid hormone receptor type 1 are expressed in human medulloblastomas and regulate cell proliferation and apoptosis in medulloblastoma-derived cell lines. Acta Neuropathol. 2007, 114, 135-145.
81. Garcia-Esparcia, P.; Schluter, A.; Carmona, M.; Moreno, J.; Ansoleaga, B.; Torrejon-Escribano, B.; Gustincich, S.; Pujol, A.; Ferrer, I. Functional genomics reveals dysregulation of cortical olfactory receptors in parkinson disease: Novel putative chemoreceptors in the human brain. J. Neuropathol. Exp. Neurol. 2013, 72, 524-539.
82. Shati, A.A.; Elsaid, F.G.; Hafez, E.E. Biochemical and molecular aspects of aluminium chloride-induced neurotoxicity in mice and the protective role of crocus sativus l. Extraction and honey syrup. Neuroscience 2011, 175, 66-74.
83. Juhasz, K.; Zvara, A.; Lipp, A.M.; Nimmervoll, B.; Sonnleitner, A.; Balogi, Z.; Duda, E. Casein kinase 2-interacting protein-1, an inflammatory signaling molecule interferes with tnf reverse signaling in human model cells. Immunol. Lett. 2013, 152, 55-64.
84. Tsunoda, T.; Ota, T.; Fujimoto, T.; Doi, K.; Tanaka, Y.; Yoshida, Y.; Ogawa, M.; Matsuzaki, H.; Hamabashiri, M.; Tyson, D.R.; et al. Inhibition of phosphodiesterase-4 (pde4) activity triggers luminal apoptosis and akt dephosphorylation in a 3-d colonic-crypt model. Mol. Cancer 2012, 11, 46.
85. Kim, S.W.; Rai, D.; McKeller, M.R.; Aguiar, R.C. Rational combined targeting of phosphodiesterase 4b and syk in dlbcl. Blood 2009, 113, 6153-6160.
86. Svoboda, N.; Zierler, S.; Kerschbaum, H.H. Camp mediates ammonia-induced programmed cell death in the microglial cell line bv-2. Eur. J. Neurosci. 2007, 25, 2285-2295.
87. Fatemi, S.H.; King, D.P.; Reutiman, T.J.; Folsom, T.D.; Laurence, J.A.; Lee, S.; Fan, Y.T.; Paciga, S.A.; Conti, M.; Menniti, F.S. Pde4b polymorphisms and decreased pde4b expression are associated with schizophrenia. Schizophr. Res. 2008, 101, 36-49.
88. Zeng, W.; Kong, Q.; Li, C.; Mao, B. Xenopus rcor2 (rest corepressor 2) interacts with zmynd8, which is involved in neural differentiation. Biochem. Biophys. Res. Commun. 2010, 394, 1024-1029.
89. Lee, S.H.; Chen, T.; Zhou, J.; Hofmann, J.; Bepler, G. Protein kinase c-beta gene variants, pathway activation, and enzastaurin activity in lung cancer. Clin. Lung Cancer 2010, 11, 169-175.
90. Lim, S.; Naisbitt, S.; Yoon, J.; Hwang, J.I.; Suh, P.G.; Sheng, M.; Kim, E. Characterization of the shank family of synaptic proteins. Multiple genes, alternative splicing, and differential expression in brain and development. J. Biol. Chem. 1999, 274, 29510-29518.
91. Boeckers, T.M.; Bockmann, J.; Kreutz, M.R.; Gundelfinger, E.D. Prosap/shank proteins-A family of higher order organizing molecules of the postsynaptic density with an emerging role in human neurological disease. J. Neurochem. 2002, 81, 903-910.
92. Park, E.; Na, M.; Choi, J.; Kim, S.; Lee, J.R.; Yoon, J.; Park, D.; Sheng, M.; Kim, E. The shank family of postsynaptic density proteins interacts with and promotes synaptic accumulation of the beta pix guanine nucleotide exchange factor for rac1 and cdc42. J. Biol. Chem. 2003, 278, 19220-19229.
93. Naisbitt, S.; Kim, E.; Weinberg, R.J.; Rao, A.; Yang, F.C.; Craig, A.M.; Sheng, M. Characterization of guanylate kinase-associated protein, a postsynaptic density protein at excitatory synapses that interacts directly with postsynaptic density-95/synapse-associated protein 90. J. Neurosci. 1997, 17, 5687-5696.
94. Boeckers, T.M.; Winter, C.; Smalla, K.H.; Kreutz, M.R.; Bockmann, J.; Seidenbecher, C.; Garner, C.C.; Gundelfinger, E.D. Proline-rich synapse-associated proteins prosap1 and prosap2 interact with synaptic proteins of the sapap/gkap family. Biochem. Biophys. Res. Commun. 1999, 264, 247-252.
95. Moutin, E.; Raynaud, F.; Fagni, L.; Perroy, J. Gkap-dlc2 interaction organizes the postsynaptic scaffold complex to enhance synaptic nmda receptor activity. J. Cell Sci. 2012, 125, 2030-2040.
96. Grabrucker, A.M. A role for synaptic zinc in prosap/shank psd scaffold malformation in autism spectrum disorders. Dev. Neurobiol. 2014, 74, 136-146.
97. Li, J.M.; Lu, C.L.; Cheng, M.C.; Luu, S.U.; Hsu, S.H.; Chen, C.H. Genetic analysis of the dlgap1 gene as a candidate gene for schizophrenia. Psychiatry Res. 2013, 205, 13-17.
98. Liu, C.; Lin, C.; Whitaker, D.T.; Bakeri, H.; Bulgakov, O.V.; Liu, P.; Lei, J.; Dong, L.; Li, T.; Swaroop, A. Prickle1 is expressed in distinct cell populations of the central nervous system and contributes to neuronal morphogenesis. Hum. Mol. Genet. 2013, 22, 2234-2246.
99. Fujimura, L.; Hatano, M. Role of prickle1 and prickle2 in neurite outgrowth in murine neuroblastoma cells. Methods Mol. Biol. 2012, 839, 173-185.
100. Fujimura, L.; Watanabe-Takano, H.; Sato, Y.; Tokuhisa, T.; Hatano, M. Prickle promotes neurite outgrowth via the dishevelled dependent pathway in c1300 cells. Neurosci. Lett. 2009, 467, 6-10.
101. Bassuk, A.G.; Wallace, R.H.; Buhr, A.; Buller, A.R.; Afawi, Z.; Shimojo, M.; Miyata, S.; Chen, S.; Gonzalez-Alegre, P.; Griesbach, H.L.; et al. A homozygous mutation in human prickle1 causes an autosomal-recessive progressive myoclonus epilepsy-ataxia syndrome. Am. J. Hum. Genet. 2008, 83, 572-581.
102. Toyoshima, Y.; Karas, M.; Yakar, S.; Dupont, J.; Lee, H.; LeRoith, D. Tdag51 mediates the effects of insulin-like growth factor i (igf-i) on cell survival. J. Biol. Chem. 2004, 279, 25898-25904.
103. Murata, T.; Sato, T.; Kamoda, T.; Moriyama, H.; Kumazawa, Y.; Hanada, N. Differential susceptibility to hydrogen sulfide-induced apoptosis between phlda1-overexpressing oral cancer cell lines and oral keratinocytes: Role of phlda1 as an apoptosis suppressor. Exp. Cell Res. 2014, 320, 247-257.
104. Park, E.S.; Kim, J.; Ha, T.U.; Choi, J.S.; Soo Hong, K.; Rho, J. Tdag51 deficiency promotes oxidative stress-induced apoptosis through the generation of reactive oxygen species in mouse embryonic fibroblasts. Exp. Mol. Med. 2013, 45, e35.
105. Xi, Z.Q.; Wang, L.Y.; Sun, J.J.; Liu, X.Z.; Zhu, X.; Xiao, F.; Guan, L.F.; Li, J.M.; Wang, L.; Wang, X.F. Tdag51 in the anterior temporal neocortex of patients with intractable epilepsy. Neurosci. Lett. 2007, 425, 53-58.
106. Van Wayenbergh, R.; Taelman, V.; Pichon, B.; Fischer, A.; Kricha, S.; Gessler, M.; Christophe, D.; Bellefroid, E.J. Identification of boip, a novel cdna highly expressed during spermatogenesis that encodes a protein interacting with the orange domain of the hairy-related transcription factor hrt1/hey1 in xenopus and mouse. Dev. Dyn. 2003, 228, 716-725.
107. Jacot, T.A.; Zalenskaya, I.; Mauck, C.; Archer, D.F.; Doncel, G.F. Tspy4 is a novel sperm-specific biomarker of semen exposure in human cervicovaginal fluids; potential use in hiv prevention and contraception studies. Contraception 2013, 88, 387-395.
108. Kido, T.; Schubert, S.; Schmidtke, J.; Chris Lau, Y.F. Expression of the human tspy gene in the brains of transgenic mice suggests a potential role of this y chromosome gene in neural functions. Yi Chuan Xue Bao 2011, 38, 181-191. (in Chinese)
109. Williams, M.; Lyu, M.S.; Yang, Y.L.; Lin, E.P.; Dunbrack, R.; Birren, B.; Cunningham, J.; Hunter, K. Ier5, a novel member of the slow-kinetics immediate-early genes. Genomics 1999, 55, 327-334.
110. Cirelli, C.; Tononi, G. Gene expression in the brain across the sleep-waking cycle. Brain Res. 2000, 885, 303-321.
111. Baye, T.M.; Wilke, R.A.; Olivier, M. Genomic and geographic distribution of private snps and pathways in human populations. Personal. Med. 2009, 6, 623-641.
112. Konishi, Y.; Aoki, T.; Ohkawa, N.; Matsu-Ura, T.; Mikoshiba, K.; Tamura, T. Identification of the C-terminal activation domain of the neurod-related factor (ndrf). Nucleic Acids Res. 2000, 28, 2406-2412.
113. Bormuth, I.; Yan, K.; Yonemasu, T.; Gummert, M.; Zhang, M.; Wichert, S.; Grishina, O.; Pieper, A.; Zhang, W.; Goebbels, S.; et al. Neuronal basic helix-loop-helix proteins neurod2/6 regulate cortical commissure formation before midline interactions. J. Neurosci. 2013, 33, 641-651.
114. Schwab, M.H.; Bartholomae, A.; Heimrich, B.; Feldmeyer, D.; Druffel-Augustin, S.; Goebbels, S.; Naya, F.J.; Zhao, S.; Frotscher, M.; Tsai, M.J.; et al. Neuronal basic helix-loop-helix proteins (nex and beta2/neuro d) regulate terminal granule cell differentiation in the hippocampus. J. Neurosci. 2000, 20, 3714-3724.
115. Konishi, Y.; Matsu-ura, T.; Mikoshiba, K.; Tamura, T. Stimulation of gene expression of neurod-related factor in the mouse brain following pentylenetetrazol-induced seizures. Brain Res. 2001, 97, 129-136.
116. Lin, C.H.; Hansen, S.; Wang, Z.; Storm, D.R.; Tapscott, S.J.; Olson, J.M. The dosage of the neurod2 transcription factor regulates amygdala development and emotional learning. Proc. Natl. Acad. Sci. USA 2005, 102, 14877-14882.
117. Lin, C.H.; Stoeck, J.; Ravanpay, A.C.; Guillemot, F.; Tapscott, S.J.; Olson, J.M. Regulation of neurod2 expression in mouse brain. Dev. Biol. 2004, 265, 234-245.
118. Olson, J.M.; Asakura, A.; Snider, L.; Hawkes, R.; Strand, A.; Stoeck, J.; Hallahan, A.; Pritchard, J.; Tapscott, S.J. Neurod2 is necessary for development and survival of central nervous system neurons. Dev. Biol. 2001, 234, 174-187.
119. Flames, N.; Hobert, O. Gene regulatory logic of dopamine neuron differentiation. Nature 2009, 458, 885-889.
120. Abe, H.; Okazawa, M.; Nakanishi, S. The etv1/er81 transcription factor orchestrates activity-dependent gene regulation in the terminal maturation program of cerebellar granule cells. Proc. Natl. Acad. Sci. USA 2011, 108, 12497-12502.
121. Abe, H.; Okazawa, M.; Nakanishi, S. Gene regulation via excitation and bdnf is mediated by induction and phosphorylation of the etv1 transcription factor in cerebellar granule cells. Proc. Natl. Acad. Sci. USA 2012, 109, 8734-8739.
122. Tuoc, T.C.; Stoykova, A. Er81 is a downstream target of pax6 in cortical progenitors. BMC Dev. Biol. 2008, 8, 23.
123. Arber, S.; Ladle, D.R.; Lin, J.H.; Frank, E.; Jessell, T.M. Ets gene er81 controls the formation of functional connections between group ia sensory afferents and motor neurons. Cell 2000, 101, 485-498.
124. Zhang, Z.; Pinto, A.M.; Wan, L.; Wang, W.; Berg, M.G.; Oliva, I.; Singh, L.N.; Dengler, C.; Wei, Z.; Dreyfuss, G. Dysregulation of synaptogenesis genes antecedes motor neuron pathology in spinal muscular atrophy. Proc. Natl. Acad. Sci. USA 2013, 110, 19348-19353.
125. Chen, Y.; Zou, H.; Yang, L.Y.; Li, Y.; Wang, L.; Hao, Y.; Yang, J.L. Er81-shrna inhibits growth of triple-negative human breast cancer cell line mda-mb-231 in vivo and in vitro. Asian Pac. J. Cancer Prev. 2012, 13, 2385-2392.
126. Scheer, E.; Delbac, F.; Tora, L.; Moras, D.; Romier, C. Tfiid taf6-taf9 complex formation involves the heat repeat-containing C-terminal domain of taf6 and is modulated by taf5 protein. J. Biol. Chem. 2012, 287, 27580-27592.
127. Wilhelm, E.; Kornete, M.; Targat, B.; Vigneault-Edwards, J.; Frontini, M.; Tora, L.; Benecke, A.; Bell, B. Taf6delta orchestrates an apoptotic transcriptome profile and interacts functionally with p53. BMC Mol. Biol. 2010, 11, 10.
128. Mizuta, T.R.; Fukita, Y.; Miyoshi, T.; Shimizu, A.; Honjo, T. Isolation of cdna encoding a binding protein specific to 5'-phosphorylated single-stranded DNA with g-rich sequences. Nucleic Acids Res. 1993, 21, 1761-1766.
129. Krieger, F.; Elflein, N.; Ruiz, R.; Guerra, J.; Serrano, A.L.; Asan, E.; Tabares, L.; Jablonka, S. Fast motor axon loss in smard1 does not correspond to morphological and functional alterations of the NMJ. Neurobiol. Dis. 2013, 54, 169-182.
130. Tachi, N.; Kikuchi, S.; Kozuka, N.; Nogami, A. A new mutation of ighmbp2 gene in spinal muscular atrophy with respiratory distress type 1. Pediatr. Neurol. 2005, 32, 288-290.
131. Hinks, G.L.; Shah, B.; French, S.J.; Campos, L.S.; Staley, K.; Hughes, J.; Sofroniew, M.V. Expression of lim protein genes lmo1, lmo2, and lmo3 in adult mouse hippocampus and other forebrain regions: Differential regulation by seizure activity. J. Neurosci. 1997, 17, 5549-5559.
132. Herberth, B.; Minko, K.; Csillag, A.; Jaffredo, T.; Madarasz, E. Scl, gata-2 and lmo2 expression in neurogenesis. Int. J. Dev. Neurosci. 2005, 23, 449-463.
133. Kulemzina, I.; Schumacher, M.R.; Verma, V.; Reiter, J.; Metzler, J.; Failla, A.V.; Lanz, C.; Sreedharan, V.T.; Ratsch, G.; Ivanov, D. Cohesin rings devoid of scc3 and pds5 maintain their stable association with the DNA. PLoS Genet. 2012, 8, e1002856.
134. Chan, K.L.; Gligoris, T.; Upcher, W.; Kato, Y.; Shirahige, K.; Nasmyth, K.; Beckouet, F. Pds5 promotes and protects cohesin acetylation. Proc. Natl. Acad. Sci. USA 2013, 110, 13020-13025.
135. Ren, Q.; Yang, H.; Rosinski, M.; Conrad, M.N.; Dresser, M.E.; Guacci, V.; Zhang, Z. Mutation of the cohesin related gene pds5 causes cell death with predominant apoptotic features in saccharomyces cerevisiae during early meiosis. Mutat. Res. 2005, 570, 163-173.
136. Zhang, B.; Chang, J.; Fu, M.; Huang, J.; Kashyap, R.; Salavaggione, E.; Jain, S.; Kulkarni, S.; Deardorff, M.A.; Uzielli, M.L.; et al. Dosage effects of cohesin regulatory factor pds5 on mammalian development: Implications for cohesinopathies. PLoS One 2009, 4, e5232.
137. Hur, S.K.; Park, E.J.; Han, J.E.; Kim, Y.A.; Kim, J.D.; Kang, D.; Kwon, J. Roles of human ino80 chromatin remodeling enzyme in DNA replication and chromosome segregation suppress genome instability. Cell. Mol. Life Sci. 2010, 67, 2283-2296.
138. Seeber, A.; Dion, V.; Gasser, S.M. Checkpoint kinases and the ino80 nucleosome remodeling complex enhance global chromatin mobility in response to DNA damage. Genes Dev. 2013, 27, 1999-2008.
139. Park, E.J.; Hur, S.K.; Kwon, J. Human ino80 chromatin-remodelling complex contributes to DNA double-strand break repair via the expression of rad54b and xrcc3 genes. Biochem. J. 2010, 431, 179-187.
140. Fischle, W.; Franz, H.; Jacobs, S.A.; Allis, C.D.; Khorasanizadeh, S. Specificity of the chromodomain y chromosome family of chromodomains for lysine-methylated ark(s/t) motifs. J. Biol. Chem. 2008, 283, 19626-19635.
141. Gu, P.; Min, J.N.; Wang, Y.; Huang, C.; Peng, T.; Chai, W.; Chang, S. Ctc1 deletion results in defective telomere replication, leading to catastrophic telomere loss and stem cell exhaustion. EMBO J. 2012, 31, 2309-2321.
142. Chen, L.Y.; Redon, S.; Lingner, J. The human cst complex is a terminator of telomerase activity. Nature 2012, 488, 540-544.
143. Kasbek, C.; Wang, F.; Price, C.M. Human ten1 maintains telomere integrity and functions in genome-wide replication restart. J. Biol. Chem. 2013, 288, 30139-30150.
144. Gramatges, M.M.; Bertuch, A.A. Short telomeres: From dyskeratosis congenita to sporadic aplastic anemia and malignancy. Transl. Res. 2013, 162, 353-363.
145. Lee, K.D.; Pai, M.Y.; Hsu, C.C.; Chen, C.C.; Chen, Y.L.; Chu, P.Y.; Lee, C.H.; Chen, L.T.; Chang, J.Y.; Huang, T.H.; et al. Targeted casp8ap2 methylation increases drug resistance in mesenchymal stem cells and cancer cells. Biochem. Biophys. Res. Commun. 2012, 422, 578-585.
146. Kumral, A.; Tuzun, F.; Tugyan, K.; Ozbal, S.; Yilmaz, O.; Yesilirmak, C.D.; Duman, N.; Ozkan, H. Role of epigenetic regulatory mechanisms in neonatal hypoxic-ischemic brain injury. Early Hum. Dev. 2013, 89, 165-173.
147. Imai, Y.; Kimura, T.; Murakami, A.; Yajima, N.; Sakamaki, K.; Yonehara, S. The ced-4-homologous protein flash is involved in fas-mediated activation of caspase-8 during apoptosis. Nature 1999, 398, 777-785.
148. Yang, X.C.; Burch, B.D.; Yan, Y.; Marzluff, W.F.; Dominski, Z. Flash, a proapoptotic protein involved in activation of caspase-8, is essential for 3' end processing of histone pre-mrnas. Mol. Cell 2009, 36, 267-278.
149. Burmester, T.; Ebner, B.; Weich, B.; Hankeln, T. Cytoglobin: A novel globin type ubiquitously expressed in vertebrate tissues. Mol. Biol. Evolut. 2002, 19, 416-421.
150. Ascenzi, P.; Marino, M.; Polticelli, F.; Coletta, M.; Gioia, M.; Marini, S.; Pesce, A.; Nardini, M.; Bolognesi, M.; Reeder, B.J.; et al. Non-covalent and covalent modifications modulate the reactivity of monomeric mammalian globins. Biochim. Biophys. Acta 2013, 1834, 1750-1756.
151. Tian, S.F.; Yang, H.H.; Xiao, D.P.; Huang, Y.J.; He, G.Y.; Ma, H.R.; Xia, F.; Shi, X.C. Mechanisms of neuroprotection from hypoxia-ischemia (hi) brain injury by up-regulation of cytoglobin (cygb) in a neonatal rat model. J. Biol. Chem. 2013, 288, 15988-16003.
152. Hundahl, C.A.; Elfving, B.; Muller, H.K.; Hay-Schmidt, A.; Wegener, G. A gene-environment study of cytoglobin in the human and rat hippocampus. PLoS One 2013, 8, e63288.
153. Beltran-Parrazal, L.; Acuna, D.; Ngan, A.M.; Kim, E.; Ngan, A.; Kawakami, K.; Edmond, J.; Lopez, I.A. Neuroglobin, cytoglobin, and transcriptional profiling of hypoxia-related genes in the rat cerebellum after prenatal chronic very mild carbon monoxide exposure (25 ppm). Brain Res. 2010, 1330, 61-71.
154. Araki, T.; Milbrandt, J. Znrf proteins constitute a family of presynaptic e3 ubiquitin ligases. J. Neurosci. 2003, 23, 9385-9394.
155. Yoshida, K.; Watanabe, M.; Hatakeyama, S. Znrf1 interacts with tubulin and regulates cell morphogenesis. Biochem. Biophys. Res. Commun. 2009, 389, 506-511.
156. Saitoh, F.; Araki, T. Proteasomal degradation of glutamine synthetase regulates schwann cell differentiation. J. Neurosci. 2010, 30, 1204-1212.
157. Tidd, D.M.; Broughton, C.M.; Clark, R.E. Cpg oligodeoxynucleotide 5mer-induced apoptosis in molt-4 leukaemia cells does not require caspase 3 or new protein synthesis. Nucleic Acids Res. 2003, 31, 2297-2304.
158. Matsuki, H.; Takahashi, M.; Higuchi, M.; Makokha, G.N.; Oie, M.; Fujii, M. Both g3bp1 and g3bp2 contribute to stress granule formation. Genes Cells 2013, 18, 135-146.
159. Takahashi, M.; Higuchi, M.; Matsuki, H.; Yoshita, M.; Ohsawa, T.; Oie, M.; Fujii, M. Stress granules inhibit apoptosis by reducing reactive oxygen species production. Mol. Cell. Biol. 2013, 33, 815-829.
160. Maretzky, T.; McIlwain, D.R.; Issuree, P.D.; Li, X.; Malapeira, J.; Amin, S.; Lang, P.A.; Mak, T.W.; Blobel, C.P. Irhom2 controls the substrate selectivity of stimulated adam17-dependent ectodomain shedding. Proc. Natl. Acad. Sci. USA 2013, 110, 11433-11438.
161. Christova, Y.; Adrain, C.; Bambrough, P.; Ibrahim, A.; Freeman, M. Mammalian irhoms have distinct physiological functions including an essential role in tace regulation. EMBO Rep. 2013, 14, 884-890.
162. Hurtado, O.; Lizasoain, I.; Fernandez-Tome, P.; Alvarez-Barrientos, A.; Leza, J.C.; Lorenzo, P.; Moro, M.A. Tace/adam17-tnf-alpha pathway in rat cortical cultures after exposure to oxygen-glucose deprivation or glutamate. J. Cereb. Blood Flow Metab. 2002, 22, 576-585.
163. Meliopoulos, V.A.; Andersen, L.E.; Brooks, P.; Yan, X.; Bakre, A.; Coleman, J.K.; Tompkins, S.M.; Tripp, R.A. Microrna regulation of human protease genes essential for influenza virus replication. PLoS One 2012, 7, e37169.
164. Liu, Y.; Kern, J.T.; Walker, J.R.; Johnson, J.A.; Schultz, P.G.; Luesch, H. A genomic screen for activators of the antioxidant response element. Proc. Natl. Acad. Sci. USA 2007, 104, 5205-5210.
165. Staneviciene, I.; Sadauskiene, I.; Lesauskaite, V.; Ivanoviene, L.; Kasauskas, A.; Ivanov, L. Subacute effects of cadmium and zinc ions on protein synthesis and cell death in mouse liver. Medicina 2008, 44, 131-138.
166. Munakata, K.; Iwamoto, K.; Bundo, M.; Kato, T. Mitochondrial DNA 3243A > G mutation and increased expression of lars2 gene in the brains of patients with bipolar disorder and schizophrenia. Biol. Psychiatry 2005, 57, 525-532.
167. Haitina, T.; Lindblom, J.; Renstrom, T.; Fredriksson, R. Fourteen novel human members of mitochondrial solute carrier family 25 (slc25) widely expressed in the central nervous system. Genomics 2006, 88, 779-790.
168. Fiermonte, G.; Paradies, E.; Todisco, S.; Marobbio, C.M.; Palmieri, F. A novel member of solute carrier family 25 (slc25a42) is a transporter of coenzyme a and adenosine 3',5'-diphosphate in human mitochondria. J. Biol. Chem. 2009, 284, 18152-18159.
169. Palmieri, F. The mitochondrial transporter family (slc25): Physiological and pathological implications. Pflugers Arch. 2004, 447, 689-709.
170. Zhang, H.; Chen, X.; Sairam, M.R. Novel genes of visceral adiposity: Identification of mouse and human mesenteric estrogen-dependent adipose (meda)-4 gene and its adipogenic function. Endocrinology 2012, 153, 2665-2676.
171. Stolzing, A.; Grune, T. Neuronal apoptotic bodies: Phagocytosis and degradation by primary microglial cells. FASEB J. 2004, 18, 743-745.
172. Prager-Khoutorsky, M.; Spira, M.E. Neurite retraction and regrowth regulated by membrane retrieval, membrane supply, and actin dynamics. Brain Res. 2009, 1251, 65-79.
173. Klein, M.E.; Younts, T.J.; Castillo, P.E.; Jordan, B.A. Rna-binding protein sam68 controls synapse number and local beta-actin mrna metabolism in dendrites. Proc. Natl. Acad. Sci. USA 2013, 110, 3125-3130.
174. Ghosh, T.; Soni, K.; Scaria, V.; Halimani, M.; Bhattacharjee, C.; Pillai, B. Microrna-mediated up-regulation of an alternatively polyadenylated variant of the mouse cytoplasmic β-actin gene. Nucleic Acids Res. 2008, 36, 6318-6332.
175. Ferreira, E.; Cronje, M.J. Selection of suitable reference genes for quantitative real-time PCR in apoptosis-induced mcf-7 breast cancer cells. Mol. Biotechnol. 2012, 50, 121-128.
176. Riviere, J.B.; van Bon, B.W.; Hoischen, A.; Kholmanskikh, S.S.; O'Roak, B.J.; Gilissen, C.; Gijsen, S.; Sullivan, C.T.; Christian, S.L.; Abdul-Rahman, O.A.; et al. De novo mutations in the actin genes actb and actg1 cause baraitser-winter syndrome. Nat. Genet. 2012, 44, 440-444.
177. Miwa, T.; Manabe, Y.; Kurokawa, K.; Kamada, S.; Kanda, N.; Bruns, G.; Ueyama, H.; Kakunaga, T. Structure, chromosome location, and expression of the human smooth muscle (enteric type) γ-actin gene: Evolution of six human actin genes. Mol. Cell. Biol. 1991, 11, 3296-3306.
178. Kumar, A.; Crawford, K.; Close, L.; Madison, M.; Lorenz, J.; Doetschman, T.; Pawlowski, S.; Duffy, J.; Neumann, J.; Robbins, J.; et al. Rescue of cardiac alpha-actin-deficient mice by enteric smooth muscle gamma-actin. Proc. Natl. Acad. Sci. USA 1997, 94, 4406-4411.
179. Li, G.Y.; Kim, M.; Kim, J.H.; Lee, M.O.; Chung, J.H.; Lee, B.H. Gene expression profiling in human lung fibroblast following cadmium exposure. Food Chem. Toxicol. 2008, 46, 1131-1137.
180. Marshall, T.W.; Aloor, H.L.; Bear, J.E. Coronin 2a regulates a subset of focal-adhesion-turnover events through the cofilin pathway. J. Cell Sci. 2009, 122, 3061-3069.
181. Huang, W.; Ghisletti, S.; Saijo, K.; Gandhi, M.; Aouadi, M.; Tesz, G.J.; Zhang, D.X.; Yao, J.; Czech, M.P.; Goode, B.L.; et al. Coronin 2a mediates actin-dependent de-repression of inflammatory response genes. Nature 2011, 470, 414-418.
182. Franco, D.L.; Rezaval, C.; Caceres, A.; Schinder, A.F.; Ceriani, M.F. Ena/vasp downregulation triggers cell death by impairing axonal maintenance in hippocampal neurons. Mol. Cell. Neurosci. 2010, 44, 154-164.
183. Krause, M.; Leslie, J.D.; Stewart, M.; Lafuente, E.M.; Valderrama, F.; Jagannathan, R.; Strasser, G.A.; Rubinson, D.A.; Liu, H.; Way, M.; et al. Lamellipodin, an ena/vasp ligand, is implicated in the regulation of lamellipodial dynamics. Dev. Cell 2004, 7, 571-583.
184. Klostermann, A.; Lutz, B.; Gertler, F.; Behl, C. The orthologous human and murine semaphorin 6a-1 proteins (sema6a-1/sema6a-1) bind to the enabled/vasodilator-stimulated phosphoprotein-like protein (evl) via a novel carboxyl-terminal zyxin-like domain. J. Biol. Chem. 2000, 275, 39647-39653.
185. Kubota, K.; Kim, J.Y.; Sawada, A.; Tokimasa, S.; Fujisaki, H.; Matsuda-Hashii, Y.; Ozono, K.; Hara, J. Lrrc8 involved in b cell development belongs to a novel family of leucine-rich repeat proteins. FEBS Lett. 2004, 564, 147-152.
186. Herrick, S.; Evers, D.M.; Lee, J.Y.; Udagawa, N.; Pak, D.T. Postsynaptic pdlim5/enigma homolog binds spar and causes dendritic spine shrinkage. Mol. Cell. Neurosci. 2010, 43, 188-200.
187. Hussain, N.K.; Yamabhai, M.; Bhakar, A.L.; Metzler, M.; Ferguson, S.S.; Hayden, M.R.; McPherson, P.S.; Kay, B.K. A role for epsin n-terminal homology/ap180 n-terminal homology (enth/anth) domains in tubulin binding. J. Biol. Chem. 2003, 278, 28823-28830.
188. Romanitan, M.O.; Popescu, B.O.; Spulber, S.; Bajenaru, O.; Popescu, L.M.; Winblad, B.; Bogdanovic, N. Altered expression of claudin family proteins in alzheimer's disease and vascular dementia brains. J. Cell. Mol. Med. 2010, 14, 1088-1100.
189. Bruggeman, L.A.; Martinka, S.; Simske, J.S. Expression of tm4sf10, a claudin/emp/pmp22 family cell junction protein, during mouse kidney development and podocyte differentiation. Dev. Dyn. 2007, 236, 596-605.
190. Laketa, V.; Simpson, J.C.; Bechtel, S.; Wiemann, S.; Pepperkok, R. High-content microscopy identifies new neurite outgrowth regulators. Mol. Biol. Cell 2007, 18, 242-252.
191. Laumet, G.; Petitprez, V.; Sillaire, A.; Ayral, A.M.; Hansmannel, F.; Chapuis, J.; Hannequin, D.; Pasquier, F.; Scarpini, E.; Galimberti, D.; et al. A study of the association between the adam12 and sh3pxd2a (sh3md1) genes and Alzheimer's disease. Neurosci. Lett. 2010, 468, 1-2.
192. Harold, D.; Jehu, L.; Turic, D.; Hollingworth, P.; Moore, P.; Summerhayes, P.; Moskvina, V.; Foy, C.; Archer, N.; Hamilton, B.A.; et al. Interaction between the adam12 and sh3md1 genes may confer susceptibility to late-onset alzheimer's disease. Am. J. Med. Genet. B 2007, 144B, 448-452.
193. Malinin, N.L.; Wright, S.; Seubert, P.; Schenk, D.; Griswold-Prenner, I. Amyloid-β neurotoxicity is mediated by fish adapter protein and adam12 metalloprotease activity. Proc. Natl. Acad. Sci. USA 2005, 102, 3058-3063.
194. Levi, G.; Aloisi, F.; Ciotti, M.T.; Gallo, V. Autoradiographic localization and depolarization-induced release of acidic amino acids in differentiating cerebellar granule cell cultures. Brain Res. 1984, 290, 77-86.